Soluble intercellular adhesion molecule-1 levels of patients with acute myeloid leukemia after allogeneic bone marrow transplantation.
Concentrations of serum-soluble intercellular adhesion molecule-1 (ICAM-1) were measured for 10 patients with or without chronic graft versus host disease after allogeneic bone marrow transplantation. Levels of soluble ICAM-1 were higher among patients with chronic graft versus host disease than among those without it, a statistically significant difference. The results indicated that measurement of serum-soluble ICAM-1 is useful for prediction of chronic graft versus host disease.
Maeda
Y
Y
Third Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.
Chihara
J
J
Sumimoto
Y
Y
Yamada
H
H
Miyatake
J
J
Matsuda
M
M
Horiuchi
F
F
Irimajiri
K
K
Horiuchi
A
A
D000208:Acute Disease; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006086:Graft vs Host Disease / Q000097:blood; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007951:Leukemia, Myeloid / Q000097:blood*; D012995:Solubility
D018799:Intercellular Adhesion Molecule-1